Lecithins, egg
Based on 1 publication(s) in Google Scholar
Lecithins, egg (Lecithins, egg yolk; Belovo PL 85) is an orally active natural phospholipid mixture extracted from egg yolks. Lecithins, egg inhibits the activities of acetylcholinesterase (AChE) and angiotensin-converting enzyme (ACE). Lecithins, egg exhibits antibacterial, antioxidant and anti-inflammatory activities, and helps delay cellular senescence. Lecithins, egg enhances nerve conduction, improves memory and cognitive function, and exerts positive effects on delaying neurodegenerative diseases. Lecithins, egg promotes lipid absorption and alleviates diarrhea. Lecithins, egg acts as a high-efficiency drug carrier for the preparation of targeted drug delivery systems such as liposomes.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 98.0%
- CAS No.: 93685-90-6
-
Stockage:
-20°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
-
Solvant et solubilité
- Pureté et documentation
- Références
-
Help & FAQs
Publications Citing Use of MedChemExpress (MCE) Lecithins, egg
More
Activité biologique
Lecithins, egg (1.2 mmol/L) inhibits cholesterol absorption and transport in Caco-2 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Enteral emulsion containing Lecithins, egg (10 g/kg; p.o.; single administration) significantly improves lipid absorption in bile duct-ligated rats, with an IAUC of 849.8 mg/dL × h that is higher than that of soybean lecithin[2].
Enteral formula containing Lecithins, egg (0.6%; p.o.; ad libitum for 5 days, then fixed daily amount for 5 days) significantly improves fecal consistency in Rattus norvegicus (rats) with short bowel syndrome, with lower fecal scores compared to formula without egg yolk lecithin or with added dietary fiber[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Sprague-Dawley (male, 6-week-old, 110-130 g, bile duct-ligated)[2]
-
Dosage:10 g/kg
-
Administration:p.o.; single administration
-
Result:Showed significantly higher serum triglyceride concentration at 2 hours post-administration compared to soybean lecithin and synthetic emulsifier groups.
Showed significantly higher serum triglyceride concentration at 4 hours post-administration compared to soybean lecithin group.
Achieved an IAUC for serum triglycerides of 849.8 mg/dL × h, which was significantly higher than the soybean lecithin group's 193.6 mg/dL × h.
-
Animal Model:Sprague-Dawley (male, 7-week-old, 190-220 g, 40 cm distal small bowel resected)[2]
-
Dosage:0.6%
-
Administration:p.o.; ad libitum for 5 days, then fixed daily amount for 5 days
-
Result:Showed significantly lower fecal score compared to the dietary fiber (+) group on days 6 to 10 of test diet feeding.
Showed significantly lower fecal score compared to the egg yolk lecithin (-) group on days 4, 5, and 9.
Showed no significant difference in fecal score compared to the MCT (-) group.
Chemical Information
-
CAS No. 93685-90-6
-
Appearance Oil
-
Color Light yellow to brown
-
SMILES
[Lecithins, egg]
-
Synonyms
Lecithins, egg yolk; Belovo PL 85
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
-20°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Nat Commun
2025 May 1;16(1):4078. PMID: 40307217
Solvant et solubilité
Ethanol : ≥ 100 mg/mL
* "≥" means soluble, but saturation unknown.
Pureté et documentation
-
Fiche technique (271 KB)
-
SDS (587 KB)
- English - EN (587 KB)
- Français - FR (587 KB)
- Deutsch - DE (587 KB)
- Norwegian - NO (587 KB)
- Español - ES (587 KB)
- Swedish - SV (587 KB)
- Italian - IT (587 KB)
- Korean - KR (587 KB)
- Portuguese - PT (587 KB)
-
Instruction de manipulation (2659 KB)
Références
[1]. Zhao F, et al. Perspectives on lecithin from egg yolk: Extraction, physicochemical properties, modification, and applications. Front Nutr. 2023;9:1082671. Published 2023 Jan 6. [Content Brief]
[2]. Akashi T, et al. Enteral Formula Containing Egg Yolk Lecithin Improves Diarrhea. J Oleo Sci. 2017;66(9):1017-1027. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Lecithins, egg Related Classifications
HY-N5139 Related Classifications
Powered by Bioz
- Lecithins, egg
- 93685-90-6
- Lecithins, egg yolk
- Belovo PL 85
- Belovo PL85
- Belovo PL 85
- Belovo PL-85
- Cholinesterase (ChE)
- Angiotensin-converting Enzyme (ACE)
- Bacterial
- metabolic syndrome
- obesity
- hypertension
- Alzheimer’s disease
- acetylcholinesterase
- hyperlipidemia
- short bowel syndrome
- coronary heart disease
- angiotensin-converting enzyme
- Caco-2 cells
- Inhibitor
- inhibitor
- inhibit